‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Young African Innovators Lack Investment Not Creativity, Awards Ceremony Told 16/09/2021 Madeleine Hoecklin Africa has the highest entrepreneurship rate in the world, yet greater financial resources are needed to ensure that innovation can be implemented to strengthen health systems and the welfare of health workers, said panellists at an innovation award ceremony on Thursday. The Africa Young Innovators for Health Award, co-organised by the International Federation of Pharmaceutical […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Young African Innovators Lack Investment Not Creativity, Awards Ceremony Told 16/09/2021 Madeleine Hoecklin Africa has the highest entrepreneurship rate in the world, yet greater financial resources are needed to ensure that innovation can be implemented to strengthen health systems and the welfare of health workers, said panellists at an innovation award ceremony on Thursday. The Africa Young Innovators for Health Award, co-organised by the International Federation of Pharmaceutical […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
Young African Innovators Lack Investment Not Creativity, Awards Ceremony Told 16/09/2021 Madeleine Hoecklin Africa has the highest entrepreneurship rate in the world, yet greater financial resources are needed to ensure that innovation can be implemented to strengthen health systems and the welfare of health workers, said panellists at an innovation award ceremony on Thursday. The Africa Young Innovators for Health Award, co-organised by the International Federation of Pharmaceutical […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions 18/06/2021 Svĕt Lustig Vijay From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2. At the same time, […] Continue reading -> More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts
More Than Cables & Devices: Digital Health Event Points to Human Factors 28/05/2021 Svĕt Lustig Vijay In two decades of work on World Bank digital health initiatives, global health policy specialist Akiko Maeda found many fell short of their promises. She suggested these underperforming digital health initiatives focused too much on delivering hardware — but they failed to provide means to ensure stable electricity supplies, and similarly failed to provide adequate […] Continue reading -> Posts navigation Older postsNewer posts